CLINICAL_TRIALS
trial_result
· 2022-10-20
Clinical Trial Update: Niclosamide Role in Diabetic Nephropathy [Phase 3]
Summary
Phase 3 clinical trial investigating niclosamide for diabetic nephropathy has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Tanta University | Conditions: Diabetic Nephropathies | Phase 3 | Status: COMPLETED